Aktis Oncology, Inc. Common stock (AKTS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US01021M1045
Aktis Oncology, Inc. Common stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.49 m USD | 6.50 m USD |
| Gross profit | 1.49 m USD | 6.50 m USD |
| Operating income | -52.05 m USD | -74.68 m USD |
| EBIT | -43.98 m USD | -63.73 m USD |
| Net income | -43.98 m USD | -63.73 m USD |
| Diluted EPS – continuing operations | -1.26 USD | -1.21 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aktis Oncology, Inc. Common stock
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts.
More stocks
- CTO Realty Growth, Inc. (CTO)
- Suzhou W Deane New Power Elec (603312.SS)
- Collins Foods Ltd (CKF.AX)
- Daxin Materials Corp (5234.TW)
- China Yuchai International Ltd (CYD)
- AZUL ON N2 (AZUL3.SA)
- Huachangda Intelligent Equipment Group Co Ltd (300278.SZ)
- Xianheng International Science & Technology Co Ltd (605056.SS)
- Savencia SA (SAVE.PA)
- Immatics NV (IMTX)
- Platzer Fastigheter Holding AB (publ) (PLAZ B.ST)
- Sri Trang Gloves (Thailand) Public Company Limited (STGT.BK)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.